Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Conditions:   Pulmonary Disease, Chronic Obstructive;   Asthma
Interventions:   Drug: LAS190792 Dose 1;   Drug: LAS190792 Dose 2;   Drug: LAS190792 Dose 3;   Drug: LAS190792 Dose 4;   Drug: LAS190792 Dose 5;   Drug: LAS190792 Dose 6;   Drug: LAS190792 Dose 1 (Part 2);   Drug: LAS190792 Dose 2 (Part 2);   Drug: Tiotropium 18 ?g;   Drug: Indacaterol 150 ?g;   Drug: Placebo
Sponsor:   Almirall, S.A.
Recruiting – verified February 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days